Member access

4-Traders Homepage  >  Shares  >  NATIONAL STOCK EXCHANGE OF INDIA  >  GlaxoSmithKline Pharmaceuticals Limited    GLAXO   INE159A01016

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote National Stock Exchange O…
05/18/2015 05/19/2015 05/20/2015 05/21/2015 05/22/2015 Date
3230(c) 3246(c) 3201.85(c) 3218(c) 3183.05(c) Last
21 522 5 905 7 495 3 420 4 636 Volume
-0.48% +0.50% -1.36% +0.50% -1.09% Change
More quotes
Financials ( INR)
Sales 2015 32 944 M
EBIT 2015 6 566 M
Net income 2015 4 763 M
Finance 2015 20 689 M
Yield 2015 1,93%
Sales 2016 -
EBIT 2016 -
Net income 2016 -
Debt 2016 -
Yield 2016 -
PER 2015 56,80
PER 2016 -
Capi. / Sales 2015 7,58x
Capi. / Sales 2016 -
Capitalization 270 385 M
More Financials
Company
GlaxoSmithKline Pharmaceuticals Ltd. engages in the business of manufacturing, distributing and trading in pharmaceuticals.The company's product portfolio includes prescription medicines and vaccines.Its prescription medicines range across therapeutic areas such as anti-infective, dermatology,... 
More about the company
Surperformance© ratings of GlaxoSmithKline Pharmaceut
Trading Rating : - Investor Rating :
More Ratings
Latest news on GLAXOSMITHKLINE PHARMACEUT
05/20 GLAXOSMITHKLINE PHARMACEUTICALS : Results for fifteen months period ending March..
05/17 GLAXOSMITHKLINE : New shingles vaccine puts patients in quandary
05/06 UPDATE : Glaxo Slashes Return To Shareholders, Sets Out Growth Guidance
05/06 INTU PROPERTIES : LONDON MIDDAY BRIEFING: Glaxo Slashes Shareholder Payout Plans
05/06 Glaxo Slashes Return To Shareholders, Sets Out Guidance Through To 2020
05/01 GLAXOSMITHKLINE : Says US FDA Approves Breo Ellipta For Asthma In Adults
04/30 GLAXOSMITHKLINE PHARMACEUTICALS : FDA approves Glaxo's inhaler drug Breo Ellipta..
04/30 GLAXOSMITHKLINE PHARMACEUTICALS : Glaxo gets OK to expand marketing of inhaler d..
More news
Sector news : Pharmaceuticals - NEC
05/23 GERMANY'S MERCK EXPECTS DRUG DIVISIO : Euro am Sonntag
05/22DJAmgen Ends Psoriasis-Drug Partnership With AstraZeneca -- Update
05/22 AMGEN : ends work on experimental psoriasis drug
More sector news : Pharmaceuticals - NEC


Comments 
Advertisement
Chart GLAXOSMITHKLINE PHARMACEUT
Duration : Period :
GlaxoSmithKline Pharmaceut Technical Analysis Chart | GLAXO | INE159A01016 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions